Adenocarcinoma in situ of the cervix:: Management and outcome

被引:75
|
作者
Azodi, M [1 ]
Chambers, SK [1 ]
Rutherford, TJ [1 ]
Kohorn, EI [1 ]
Schwartz, PE [1 ]
Chambers, JT [1 ]
机构
[1] Yale Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, New Haven, CT 06520 USA
关键词
D O I
10.1006/gyno.1999.5395
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The aim of this study was to review the management and outcome of patients with adenocarcinoma in situ of the cenix and to evaluate the significance of endocervical cone margin status in these patients. Methods. A retrospective review of records between January 1988 and December 1996 identified 40 patients with adenocarcinoma in situ on cone biopsy for whom complete information was available. The median follow-up was 38 months. Results. The mean age was 37 years, and the mean parity was 1.3. Fifty-three percent of the patients had prior abnormal cervical cytology. The initial Pap smear that led to the patient's referral was abnormal in 39 (98%). Initial cervical biopsies showed adenocarcinoma in situ and/or glandular dysplasia in 28 (70%), squamous dysplasia in 2 (5%), chronic inflammation in 2 (5%), and no pathologic changes in 2 (5%) patients. Initially no biopsies were performed in 3 (7.5%) patients and the results of 3 (7.5%) biopsies were unknown. Subsequently, all patients had cone biopsies. The endocervical margins were positive for glandular abnormalities in 24% of cold knife cones (CKC), 75% of LEEPs, and 57% of laser cones. The ectocervical margins were positive for squamous and/or glandular abnormalities in 8% of CKCs, 13% of LEEPs, and 57% of laser cones. ECCs above the cone were obtained in 28 patients, and only 1 (3%) was positive. The definitive treatment was hysterectomy in 27, repeat cone in 5, and no additional therapy in 8 patients. The pathology showed residual disease in 44% of treated patients. From 16 cone biopsies with negative margins who had subsequent treatment, there was residual disease in 5 (31%) specimens (1 adenocarcinoma in situ, 1 mild glandular dysplasia, 3 glandular atypia). From 16 cones with positive margins who had subsequent treatment, there was residual disease in 9 (56%) specimens. The patients with negative ECCs above the cone regardless of margin status had residual disease in 58% of treated specimens. Conclusion. Women with adenocarcinoma in situ of the uterine cenix had residual disease in 31% of cases with negative margins in cone biopsies and/or with negative ECCs and in 56% of cases with positive endocervical margins. LEEP cones had higher rate of positive endocervical margins (75%) compared to CKC (24%) and laser cone (57%). If maintaining reproductive capacity is desired, we would recommend CKC; however, this does not guarantee absence of the disease. (C) 1999 Academic Press.
引用
收藏
页码:348 / 353
页数:6
相关论文
共 50 条
  • [41] Clinical outcome of patients with microinvasive adenocarcinoma of the uterine cervix
    Meglic, L.
    Pogacnik, R. Kosir
    Rakar, S.
    Smrkolj, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2013, 34 (04) : 296 - 299
  • [42] CONSERVATIVE MANAGEMENT OF IN SITU CARCINOMA OF CERVIX
    BOYD, JR
    ROYLE, D
    FIDLER, HK
    BOYES, DA
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1963, 85 (03) : 322 - &
  • [43] CLINICAL OUTCOME OF PATIENTS WITH MICROINVASIVE ADENOCARCINOMA OF THE UTERINE CERVIX
    Smrkolj, S.
    Meglic, L.
    Pogacnik, R. Kosir
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [44] MANAGEMENT OF CARCINOMA-IN-SITU OF CERVIX
    LEWIS, TL
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1966, 59 (10): : 986 - &
  • [45] Management of Adenocarcinoma In Situ of the Uterine Cervix: A Comparison of Loop Electrosurgical Excision Procedure and Cold Knife Conization
    Latif, Nawar A.
    Neubauer, Nikki L.
    Helenowski, Irene B.
    Lurain, John R.
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2015, 19 (02) : 97 - 102
  • [46] Adenocarcinoma in situ of the cervix:: A prospective study of conization as definitive treatment
    Andersen, ES
    Nielsen, K
    GYNECOLOGIC ONCOLOGY, 2002, 86 (03) : 365 - 369
  • [47] Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix
    McHale, MT
    Le, TD
    Burger, RA
    Gu, M
    Rutgers, JL
    Monk, BJ
    OBSTETRICS AND GYNECOLOGY, 2001, 98 (05): : 726 - 731
  • [48] Clinical outcomes of patients with adenocarcinoma in situ of the cervix treated by conization
    Taylor, J. S.
    Panico, V.
    Caputo, T.
    Gerber, D.
    Gupta, D.
    Pirog, E.
    Holcomb, K.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (06) : 641 - 645
  • [49] SYNCHRONOUS SMALL CELL NEUROENDOCRINE CARCINOMA AND ADENOCARCINOMA IN SITU OF THE CERVIX
    Zovko, G.
    Madzarac, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A285 - A285
  • [50] MORPHOLOGY OF ADENOCARCINOMA IN SITU OF THE UTERINE CERVIX - A STUDY OF 14 CASES
    GLOOR, E
    RUZICKA, J
    CANCER, 1982, 49 (02) : 294 - 302